‘The Earlier, The Better’ Strategy with Evolocumab in ACS Within 1 Year
[Speaker] 김민철 / 전남의대
‘Higher Risk, Higher Benefit’ Strategy with Evolocumab in MI Over 1 Year
[Speaker] 홍순준 / 고려의대
Discussion